American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BRIGHT MINDS BIOSCIENCES INC. (DRUG)

$71.33 +0.06% NASDAQ: DRUG · 15-min delayed

NEW YORK, New York
Public · NASDAQ: DRUG
25 employees

Visit website Follow

$699.9MMarket cap

25Employees

DRUGNASDAQ

2021IPO

About BRIGHT MINDS BIOSCIENCES INC.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: DRUG
Employees: 25
IPO date: Mar 8, 2021
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: DRUG Nasdaq
SEC CIK: 1827401
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Bright Minds Biosciences Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/bright-minds-biosciences-inc/"><img src="https://americancompanies.com/badge/bright-minds-biosciences-inc.svg" alt="Bright Minds Biosciences Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow BRIGHT MINDS BIOSCIENCES INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $699.9M

NASDAQ: DRUG

$71.33 +0.06%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$23.27 $95.98

52-week range

Market cap: $699.9M
Shares outstanding: 9.5M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Mar 8, 2021

Bright Minds Biosciences Inc. (DRUG) Stock Price

Trading 26% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BRIGHT MINDS BIOSCIENCES INC..

Write a review

Newsroom

News about BRIGHT MINDS BIOSCIENCES INC.

Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference GlobeNewswire Inc. · 2026-05-26 · neutral Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline The Motley Fool · 2026-05-21 · positive Bright Minds Biosciences Announces Closing of US$175 Million Public Offering Benzinga · 2026-01-09 · positive Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock GlobeNewswire Inc. · 2026-01-08 · positive Why Bright Minds Biosciences Stock Topped the Market on Monday The Motley Fool · 2025-11-17 · positive Bright Minds Biosciences to Present at Upcoming Conferences GlobeNewswire Inc. · 2025-10-30 · positive

News & sentiment via Polygon.io

FAQ

Bright Minds Biosciences Inc.: frequently asked questions

Is Bright Minds Biosciences Inc. an American company?

Bright Minds Biosciences Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Bright Minds Biosciences Inc. headquartered?

Bright Minds Biosciences Inc. is headquartered in New York, New York, United States.

Is Bright Minds Biosciences Inc. publicly traded?

Yes — Bright Minds Biosciences Inc. is a publicly traded company. Its stock trades under the ticker symbol DRUG on the NASDAQ.

What does Bright Minds Biosciences Inc. do?

Bright Minds Biosciences Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore